Evaluation of the Memory Enhancement Effects of Aminopyrimidine Derivatives Using the Scopolamine Model of Dementia in Mice
Neurotoxicity Research · 2025
DOI: 10.1007/s12640-025-00736-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurotoxicity Research, 2025. Verfasst von Behnaz Landi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, School of Pharmacy, Shahid Beheshti University of Medical Sciences, 2660 Vali-E-Asr Ave, P.O. Box, Tehran,…. Hauptthemen laut MEDLINE: Pyrimidines, Dementia, Nootropic Agents, Memory. Die Arbeit nennt 30 Literaturangaben. Gefördert von: Research Council of Shahid Beheshti University of Medical Sciences.
Themen: Demenz
Abstract (Originalsprache)
Aminopyrimidine compounds have been gaining traction in the field of drug discovery in recent years due to their emergence as multi-targeted molecules. This makes them perfect candidates as agents for cognitive improvement, as cognitive decline is a multifaceted condition. We aim to evaluate their potential for memory enhancement, specifically through their cholinergic properties. This work examines the properties of seven aminopyrimidine derivatives and their effects on memory acquisition and retention. These compounds were administered to NMRI mice after the induction of amnesia by scopolamine, and memory impairment and improvement were assessed using passive avoidance and spontaneous alternation tests with the drug donepezil as the positive control group. These compounds were also analyzed using docking and ADME prediction studies to determine potential affinity to the acetylcholinesterase enzyme, and characterize pharmacokinetic properties, respectively. Additionally, in vitro inhibition of cholinesterase was evaluated. Results showed that three of the seven compounds significantly increased cognition in both behavioral tests. Software analysis suggested allosteric inhibition or modulation of acetylcholinesterase, signifying the potential of these compounds for further optimization and eventual utilization for treatment of cognitive impairment cases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Toxicology, School of Pharmacy, Shahid Beheshti University of Medical Sciences, 2660 Vali-E-Asr Ave, P.O. Box, Tehran, 6153- 14155, Iran.
- Phytochemistry Research Center, Shahid Beheshti University of Medical Sciences, 2660 Vali-E-Asr Ave., P.O. Box, Tehran, 6153- 14155, Iran.
- Department of Medicinal Chemistry, School of Pharmacy, Shahid Beheshti University of Medical Sciences, 2660 Vali-E-Asr Ave., P.O. Box, Tehran, 6153- 14155, Iran.
- Department of Pharmacology and Toxicology, School of Pharmacy, Shahid Beheshti University of Medical Sciences, 2660 Vali-E-Asr Ave, P.O. Box, Tehran, 6153- 14155, Iran. m.faizi@sbmu.ac.ir.
Förderung
- Research Council of Shahid Beheshti University of Medical Sciences
Zitieren
APA
Landi, B., Khoramjouy, M., Lahij, A. G., Fazelkia, S., Amidi, S., Kobarfard, F., & Faizi, M. (2025). Evaluation of the Memory Enhancement Effects of Aminopyrimidine Derivatives Using the Scopolamine Model of Dementia in Mice. Neurotoxicity Research. https://doi.org/10.1007/s12640-025-00736-4
Vancouver
Landi B, Khoramjouy M, Lahij AG, Fazelkia S, Amidi S, Kobarfard F, et al. Evaluation of the Memory Enhancement Effects of Aminopyrimidine Derivatives Using the Scopolamine Model of Dementia in Mice. Neurotoxicity Research. 2025. doi:10.1007/s12640-025-00736-4
BibTeX
@article{Landi2025,
author = {Landi, Behnaz and Khoramjouy, Mona and Lahij, Alireza Ghavami and Fazelkia, Sajjad and Amidi, Salimeh and Kobarfard, Farzad and Faizi, Mehrdad},
title = {Evaluation of the Memory Enhancement Effects of Aminopyrimidine Derivatives Using the Scopolamine Model of Dementia in Mice},
journal = {Neurotoxicity Research},
year = {2025},
doi = {10.1007/s12640-025-00736-4}
}
EUVIMED